We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NACLIND:NSENACL Industries Ltd Analysis

Data as of 2026-03-15 - not real-time

₹122.03

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: NACL Industries is trading at ₹122.03, well below its 20‑day (₹130.92), 50‑day (₹148.93) and 200‑day (₹202.08) simple moving averages, confirming a bearish price trend. The RSI sits at 36.6, hinting at modest oversold conditions, while the MACD line has just nudged above its signal line, producing a tiny bullish histogram (+0.046) and a "bullish" MACD signal. Volume is increasing, and the nearest support around ₹112.6 could act as a floor, with resistance near ₹147.6. Volatility is high at 51.9% over the past 30 days and beta is slightly negative (-0.13), indicating the stock moves independently of the broader market but with large price swings.
Fundamental outlook: Revenue grew 19% year‑over‑year to ₹14.25 bn, yet gross margin is only ~30% and the company posted a -0.4% operating margin and a -3.1% net profit margin, resulting in negative EPS (-₹2.04). Cash flow is flat, debt stands at ₹5.02 bn (debt‑to‑equity 113%), and cash reserves are modest (₹0.30 bn). The price‑to‑book ratio of 5.39 and absence of dividends further stress an overvalued profile. No analyst coverage or earnings forecasts are available, underscoring uncertainty around future performance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price approaching the near‑term support level of ₹112.6
  • recent bullish MACD crossover offering limited upside
  • high short‑term volatility could trigger rapid moves

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • continued negative earnings and thin operating margin
  • significant debt load (debt‑to‑equity >100%) limiting financial flexibility
  • absence of dividend and weak cash‑flow generation

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • structural leverage and high debt servicing risk
  • persistent unprofitability despite revenue growth
  • valuation remains well above book value with no earnings upside

Key Metrics & Analysis

Financial Health

Revenue Growth18.80%
Profit Margin-3.13%
Debt/Equity112.96
P/B Ratio5.4

Technical Analysis

TrendBearish
RSI36.6
Support₹112.62
Resistance₹147.63
MA 20₹130.92
MA 50₹148.93
MA 200₹202.08
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta-0.13
Volatility51.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.